Grim Reaper
Chief Exit Officer (CEO)
No. There is no verified dataset — from HHS, CMS, FDA, or independent drug‑price trackers — showing a 90% reduction in prescription drug prices during Trump’s term.Here’s what the data actually shows:
1.
- The Bureau of Labor Statistics’ Prescription Drug CPI shows net increases, not a 90% drop.
- Independent analyses (GoodRx, Kaiser Family Foundation) also show continued upward trends in list prices.
2.
A handful of drugs saw reductions due to:- manufacturer decisions
- generic competition
- insurance negotiations
3.
A price cannot drop more than 100%.A “500% decrease” would imply the drug company is paying you to take the medication.This phrasing is not supported by any recognized economic or regulatory metric.
4.
These included:- insulin and EpiPen discount rules
- international reference pricing proposals
- rebate rule changes
- blocked in court
- never implemented
- reversed before taking effect
- or rescinded by later administrations